Health & Personal Care
HIGH
FDA DRUG
Actavis Recalls Testosterone Gel Due to Leakage Risk
Actavis Laboratories recalled 15,944 cartons of Testosterone Gel on November 7, 2025. The recall follows a defect in the side-seal of the containers, which may allow product leakage. Consumers must stop using the product immediately and contact their healthcare providers for guidance.
TESTOSTERONE
Defective Container